Cargando…
Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Lung cancer is a leading cause of cancer-related death. Stereotactic body radiotherapy (SBRT) is the standard treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Carbon ion radiotherapy (CIRT) is a safe and effective treatment for early-stage NSCLC. However, ther...
Autores principales: | Miyasaka, Yuhei, Komatsu, Shuichiro, Abe, Takanori, Kubo, Nobuteru, Okano, Naoko, Shibuya, Kei, Shirai, Katsuyuki, Kawamura, Hidemasa, Saitoh, Jun-ichi, Ebara, Takeshi, Ohno, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825544/ https://www.ncbi.nlm.nih.gov/pubmed/33419147 http://dx.doi.org/10.3390/cancers13020176 |
Ejemplares similares
-
Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease
por: Okano, Naoko, et al.
Publicado: (2021) -
Skin Dose Reduction by Layer-Stacking Irradiation in Carbon Ion Radiotherapy for Parotid Tumors
por: Kubo, Nobuteru, et al.
Publicado: (2020) -
A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
por: Miyasaka, Yuhei, et al.
Publicado: (2021) -
Cost‐effectiveness of carbon‐ion radiotherapy versus stereotactic body radiotherapy for non‐small‐cell lung cancer
por: Okazaki, Shohei, et al.
Publicado: (2021) -
Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)